Free tool
FAERS Monitor: Clenpiq
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209589 or its brand name (Clenpiq, Citric Acid, Magnesium Oxide, Sodium Picosulfate). Reports on generic versions are filed under their own applications.
Reports
726
Serious
156
21% of reports
Hospitalization
41
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective196
- nausea107
- vomiting91
- diarrhoea62
- incorrect dose administered56
- headache53
- dizziness35
- product packaging difficult to open35
- product taste abnormal34
- therapeutic product effect incomplete33
- malaise32
- abdominal distension29
- abdominal pain upper27
- dehydration26
- pain23
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2018 | 100 |
| 2019 | 90 |
| 2020 | 45 |
| 2021 | 17 |
| 2022 | 89 |
| 2023 | 134 |
| 2024 | 118 |
| 2025 | 90 |
| 2026 | 43 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,433 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product packaging difficult to openSignal | 35 | 393.9 | 284.4 | 13,148 |
| product taste abnormalSignal | 34 | 72.9 | 52.5 | 2,336 |
| therapeutic product effect incompleteSignal | 33 | 13.4 | 9.6 | 369 |
| abdominal distensionSignal | 29 | 8.1 | 5.6 | 173 |
| incorrect dose administeredSignal | 56 | 7.1 | 5.5 | 291 |
| dehydrationSignal | 26 | 5.6 | 3.9 | 95 |
| vomitingSignal | 91 | 5.6 | 4.6 | 348 |
| drug ineffectiveSignal | 196 | 4.3 | 3.8 | 528 |
| nauseaSignal | 107 | 3.9 | 3.3 | 238 |
| abdominal pain upperSignal | 27 | 3.8 | 2.6 | 53 |
| diarrhoeaSignal | 62 | 2.8 | 2.2 | 71 |
| headacheSignal | 53 | 2.4 | 1.9 | 45 |
| malaiseSignal | 32 | 2.1 | 1.5 | 18 |
| dizzinessSignal | 35 | 2.0 | 1.5 | 18 |
| pain | 23 | 1.1 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.